[go: up one dir, main page]

AU2003218639A1 - Tumour treatment compositions comprising hsp70 and tumour necrosis factor - Google Patents

Tumour treatment compositions comprising hsp70 and tumour necrosis factor

Info

Publication number
AU2003218639A1
AU2003218639A1 AU2003218639A AU2003218639A AU2003218639A1 AU 2003218639 A1 AU2003218639 A1 AU 2003218639A1 AU 2003218639 A AU2003218639 A AU 2003218639A AU 2003218639 A AU2003218639 A AU 2003218639A AU 2003218639 A1 AU2003218639 A1 AU 2003218639A1
Authority
AU
Australia
Prior art keywords
tumour
hsp70
necrosis factor
treatment compositions
tumour necrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003218639A
Inventor
Claude Libert
Tina Mahieu
Wim Van Molle
Ben Wielockx
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiteit Gent
Vlaams Instituut voor Biotechnologie VIB
Original Assignee
Universiteit Gent
Vlaams Instituut voor Biotechnologie VIB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent, Vlaams Instituut voor Biotechnologie VIB filed Critical Universiteit Gent
Publication of AU2003218639A1 publication Critical patent/AU2003218639A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003218639A 2002-01-24 2003-01-24 Tumour treatment compositions comprising hsp70 and tumour necrosis factor Abandoned AU2003218639A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075297.8 2002-01-24
EP02075297 2002-01-24
PCT/EP2003/000786 WO2003061684A2 (en) 2002-01-24 2003-01-24 Tumour treatment compositions comprising hsp70 and tumour necrosis factor

Publications (1)

Publication Number Publication Date
AU2003218639A1 true AU2003218639A1 (en) 2003-09-02

Family

ID=27589134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003218639A Abandoned AU2003218639A1 (en) 2002-01-24 2003-01-24 Tumour treatment compositions comprising hsp70 and tumour necrosis factor

Country Status (2)

Country Link
AU (1) AU2003218639A1 (en)
WO (1) WO2003061684A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080161258A1 (en) * 2004-12-10 2008-07-03 Robert Henk Henning Hsp and Supraventricular Arrhythmia
CA2728363C (en) * 2008-06-26 2019-02-19 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity
PL2646044T3 (en) 2010-11-30 2020-03-31 Orphazyme A/S Methods for increasing intracellular activity of hsp70
JP6678676B2 (en) 2014-09-15 2020-04-08 オーファザイム エー／エス Arimoclomol formulation
US10898476B2 (en) 2016-04-13 2021-01-26 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
BR112018070653A2 (en) 2016-04-29 2019-02-05 Orphazyme As active pharmaceutical ingredient and composition
AU2021380947C1 (en) 2020-11-19 2025-02-20 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens

Also Published As

Publication number Publication date
WO2003061684A2 (en) 2003-07-31
WO2003061684A3 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004045516A9 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003281736A1 (en) Electrodes and related devices
AU2003234239A1 (en) Resection and anastomosis devices and methods
AUPS273402A0 (en) Microwave treatment of ores
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003225535A1 (en) Methods and compositions for treating cancer
AU2003233069A1 (en) Gel and powder making
EP1572093A3 (en) Improved treatment of cancer with glutamine
AU2003291480A1 (en) Composition for the prevention and treatment of inflammation of the ear
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2003215257A1 (en) Modified defensins and their use
AU2003219160A1 (en) Methods and compositions for the treatment of cancer
AU2003218639A1 (en) Tumour treatment compositions comprising hsp70 and tumour necrosis factor
AU2003291456A1 (en) Methods for promoting wound healing and uses thereof
AU2003223878A1 (en) Heating conductor and use thereof
AU2002346882A1 (en) Methods for the treatment of osteoarthritis and compositions thereof
AU2003251513A1 (en) Rsk inhibitors and therapeutic uses thereof
AU2003294684A1 (en) Ketoprofen compositions and methods of making them
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003225563A1 (en) Compositions and methods for treatment of osteoarthritis
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer
AU2003901205A0 (en) Therapeutic and prophylactic compositions and uses therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase